Medication Administration, Order Clarification, and Controlled Substance Disposition Deficiencies
Summary
Medication administration was not carried out as ordered for a resident with high blood pressure and type 2 diabetes mellitus. The resident’s physician order required hydralazine 100 mg twice daily, but the medication was to be held if systolic blood pressure was below 110 mm Hg. On two occasions, an LVN documented a systolic blood pressure of 103 mm Hg and still administered hydralazine. In a separate event, the same resident had an order for 2 units of insulin when blood glucose was between 121 and 150 mg/dL, but when the blood glucose was documented as 123 mg/dL, an LVN did not administer the ordered insulin. Medication orders were not clarified when residents’ routes of administration changed from G-tube to oral intake. One resident had a physician order to discontinue G-tube feeding and change medications to by mouth, yet a later order still directed labetalol 200 mg to be given via G-tube twice daily. During observation, the resident took medications by mouth, and an RN stated the labetalol order had not been updated after the G-tube was removed. Another resident had a dietary evaluation indicating the G-tube should be discontinued, but a physician order still directed amlodipine to be administered via G-tube daily. During observation, that resident also took medications by mouth, and the DON stated nurses should check for discrepancies and clarify orders with physicians. Medication destruction and controlled substance accountability were also deficient. Twelve non-controlled medications were destroyed on a log without a second licensed nurse signature as witness. For controlled medications, the facility could not account for discontinued Norco 5/325 mg, 41 tablets, for one resident, and could not properly document the disposition of 2,622 mL of discontinued phenobarbital 20 mg/5 mL solution for another resident. The controlled medication logs showed endorsements to the ADON, but there were no signatures documenting destruction, and the facility could not locate the medications at the time of survey exit. Staff statements indicated the phenobarbital had been handled as non-controlled medication, despite being a controlled substance.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.